Management of Tubo-ovarian Abscess: a Single Center Experience

Tubo-ovarian Abscess Clinical Trial

Official title:

Management of Tuba-ovarian Abscess: a 10 Year Single-center Experience

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04817631
• Other study ID #: TOA
• Status: Completed
• Start date: January 1, 2010
• Est. completion date: November 1, 2020

Study information

• Verified date: March 2021
• Source: Sisli Hamidiye Etfal Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Electronic database of our tertiary obstetrics and gynecology clinic was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities.

Description:

This retrospective study is conducted at Health Sciences University Turkey, Sisli Hamidiye Etfal Training and Research Hospital Department of Obstetrics and Gynecology. Electronic database was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities. A change in management strategy over the years if any will be reported.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 82
• Est. completion date: November 1, 2020
• Est. primary completion date: November 1, 2020
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• presence of a pelvic mass > 3 cm with transvaginal ultrasound or magnetic resonance imaging indication abscess

• cervical and uterine tenderness

• abdominal rebound-defense under physical examination indication peritoneal irritation

• presence of symptoms such as fever, pelvic pain and increase in laboratory infection parameters

Exclusion Criteria:

• Patients with known malignities

• Patients with incomplete data in the clinic's electronic database

• Patients who continued their treatment at other centers

Related Conditions & MeSH terms

• Abscess
• Tubo-ovarian Abscess

Intervention

Other:
• tuboovarian abscess
Evaluating the surgical and medical management of tuboovarian abscess

Locations

Country	Name	City	State
Turkey	Sisli Hamidiye Etfal Training and Research Hospital	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Sisli Hamidiye Etfal Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluating the management of tuboovarian abscess on the basis of surgical or medical modalities by assessing hospitalization duration and recurrence	Patients' demographics data (age, gravity, parity, presence of additional comorbidities and BMI) will be recorded. Their laboratory assessment of infection prior to treatment begin such as CRP an procalcitonin will be recorded. Their treatment modalities in terms of surgery or antibiothepry, duration of hospitalization and recurrence will be recorded. Statistical analysis will be done using SPSS. Student's t test will be used for comparison where necessary. Significance will be evaluated using p-value.	10 years